Lillian L. Siu, MD, FAACR
Lillian L. Siu, MD, FAACR, is a senior medical oncologist, director of the Phase I Clinical Trials Program, codirector of the Robert and Maggie Bras and Family Drug Development Program, and the clinical lead for the Tumor Immunotherapy Program at the Princess Margaret Cancer Centre in Toronto, Canada.
She is also the incoming American Association for Cancer Research president, assuming the role in April 2025.
Articles
New content coming soon.
Latest Updated Articles
Published: February 20th 2025 | Updated: February 21st 2025
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
Published: January 16th 2025 | Updated: January 29th 2025
FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
